Noxxon Pharma NV

03/12/2021 | Press release | Distributed by Public on 03/12/2021 00:58

Data Safety Monitoring Board confirms safety and validates recruitment of last patients in final high-dose cohort of NOX-A12 in Phase 1/2 brain cancer study